136 related articles for article (PubMed ID: 29086816)
1. Rapid simultaneous determination of indacaterol maleate and glycopyrronium bromide in inhaler capsules using a validated stability-indicating monolithic LC method.
Zayed S; Belal F
Chem Cent J; 2017 May; 11(1):36. PubMed ID: 29086816
[TBL] [Abstract][Full Text] [Related]
2. Validated ion pair chromatographic method for simultaneous determination and in vitro dissolution studies of indacaterol and glycopyrronium from inhaled capsule dosage form.
Salem YA; Hammouda MEA; Saleh NM; Abu El-Enin MA; El-Ashry SM
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Nov; 204():464-474. PubMed ID: 29966902
[TBL] [Abstract][Full Text] [Related]
3. Multiple analytical methods for determination of formoterol and glycopyrronium simultaneously in their novel combined metered dose inhaler.
Salem YA; Hammouda MEA; Abu El-Enin MA; El-Ashry SM
BMC Chem; 2019 Dec; 13(1):75. PubMed ID: 31384822
[TBL] [Abstract][Full Text] [Related]
4. Plackett-Burman and face-centered composite designs for development and optimization of chromatographic method for the simultaneous determination of glycopyrronium, indacaterol and mometasone in their fixed dose combination inhaler - Green profile assessment.
Youssef YM; Mahrouse MA; Mostafa EA
J Pharm Biomed Anal; 2023 Sep; 234():115553. PubMed ID: 37399700
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a rapid stability indicating HPLC-method using monolithic stationary phase and two spectrophotometric methods for determination of antihistaminic acrivastine in capsules.
Gouda AA; Hashem H; Jira T
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():480-7. PubMed ID: 24813276
[TBL] [Abstract][Full Text] [Related]
6. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial.
Hohlfeld JM; Vogel-Claussen J; Biller H; Berliner D; Berschneider K; Tillmann HC; Hiltl S; Bauersachs J; Welte T
Lancet Respir Med; 2018 May; 6(5):368-378. PubMed ID: 29477448
[TBL] [Abstract][Full Text] [Related]
7. Profile of inhaled glycopyrronium bromide as monotherapy and in fixed-dose combination with indacaterol maleate for the treatment of COPD.
Prakash A; Babu KS; Morjaria JB
Int J Chron Obstruct Pulmon Dis; 2015; 10():111-23. PubMed ID: 25609944
[TBL] [Abstract][Full Text] [Related]
8. A validated stability-indicating HPLC method for the simultaneous determination of pheniramine maleate and naphazoline hydrochloride in pharmaceutical formulations.
Huang T; Chen N; Wang D; Lai Y; Cao Z
Chem Cent J; 2014 Feb; 8(1):7. PubMed ID: 24485011
[TBL] [Abstract][Full Text] [Related]
9. Design of Experiment-Based Green UPLC-DAD Method for the Simultaneous Determination of Indacaterol, Glycopyrronium and Mometasone in their Combined Dosage Form and Spiked Human Plasma.
Tarek M; Ghoniem NS; Hegazy MA; Wagdy HA
J Chromatogr Sci; 2023 Aug; ():. PubMed ID: 37635399
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of IND/GLY (indacaterol/glycopyrronium) in COPD patients.
Demin I; Bartels C; Graham G; Bieth B; Gautier A; Tillmann HC; Sechaud R
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):405-15. PubMed ID: 27049057
[TBL] [Abstract][Full Text] [Related]
11. Indacaterol/glycopyrronium bromide fixed-dose combination for the treatment of COPD.
Schachter EN
Drugs Today (Barc); 2013 Jul; 49(7):437-46. PubMed ID: 23914352
[TBL] [Abstract][Full Text] [Related]
12. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA; Banerji D; Chapman KR; Vestbo J; Roche N; Ayers RT; Thach C; Fogel R; Patalano F; Vogelmeier CF;
N Engl J Med; 2016 Jun; 374(23):2222-34. PubMed ID: 27181606
[TBL] [Abstract][Full Text] [Related]
13. Validated Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Azelnidipine and Olmesartan in Their Combined Dosage Form.
Patel JK; Patel NK
Sci Pharm; 2014; 82(3):541-54. PubMed ID: 25853066
[TBL] [Abstract][Full Text] [Related]
14. Translational Study Searching for Synergy between Glycopyrronium and Indacaterol.
Cazzola M; Calzetta L; Segreti A; Facciolo F; Rogliani P; Matera MG
COPD; 2015 Apr; 12(2):175-81. PubMed ID: 25222881
[TBL] [Abstract][Full Text] [Related]
15. Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form.
Patel JK; Patel NK
Sci Pharm; 2014; 82(4):749-63. PubMed ID: 26279975
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous spectrophotometric determination of indacaterol and glycopyrronium in a newly approved pharmaceutical formulation using different signal processing techniques of ratio spectra.
Abdel Ghany MF; Hussein LA; Magdy N; Yamani HZ
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Mar; 157():251-257. PubMed ID: 26779820
[TBL] [Abstract][Full Text] [Related]
17. Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study.
Salomon J; Stolz D; Domenighetti G; Frey JG; Turk AJ; Azzola A; Sigrist T; Fitting JW; Schmidt U; Geiser T; Wild C; Kostikas K; Clemens A; Brutsche M
Respir Res; 2017 Jan; 18(1):13. PubMed ID: 28077140
[TBL] [Abstract][Full Text] [Related]
18. Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms.
Venkatesan S; Kannappan N; Mannemala SS
Int Sch Res Notices; 2014; 2014():849149. PubMed ID: 27437485
[TBL] [Abstract][Full Text] [Related]
19. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
[TBL] [Abstract][Full Text] [Related]
20. Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.
Kerwin E; Ferguson GT; Sanjar S; Goodin T; Yadao A; Fogel R; Maitra S; Sen B; Ayers T; Banerji D
Lung; 2017 Dec; 195(6):739-747. PubMed ID: 28993871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
